Arrhythmias as trigger for acute exacerbations of chronic obstructive pulmonary disease  by Bhatt, Surya P. et al.
Respiratory Medicine (2012) 106, 1134e1138Available online at www.sciencedirect.com
journal homepage: www.elsevier .com/locate /rmedArrhythmias as trigger for acute exacerbations
of chronic obstructive pulmonary diseaseSurya P. Bhatt a,*, Sudip Nanda b, John S. Kintzer caDivision of Pulmonary, Critical Care, and Occupational Medicine, Department of Internal Medicine, Roy J. and Lucille A.
Carver College of Medicine, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA
bDivision of Cardiology, Department of Internal Medicine, Lehigh Valley Hospital, Allentown, PA 18103, USA
cDivision of Pulmonary and Critical Care Medicine, Temple University/St Luke’s Hospital, Division of Pulmonary and
Critical Care Medicine, Bethlehem, PA 18015, USA
Received 21 December 2011; accepted 21 April 2012




COPD* Corresponding author. Tel.: þ1 31
E-mail addresses: surya-bhatt@uio
(J.S. Kintzer).
0954-6111/$ - see front matter ª 201
doi:10.1016/j.rmed.2012.04.007Summary
Purpose: Acute exacerbations of chronic obstructive pulmonary disease (COPD) sometimes
appear to occur without a precipitating cause. Heterogeneous repolarization and arrhythmias
occur in COPD patients. Given the close inter-relation between heart and lung, we hypothe-
sized that unrecognized arrhythmias might be precipitants of acute exacerbations.
Methods: Electrocardiograms (ECG) of thirty patients during acute exacerbations were
compared with ECG during stable phase. P wave dispersion was used to assess atrial depolar-
ization heterogeneity, and dispersion of QT interval to assess ventricular repolarization.
p < 0.05 was considered significant. Frequent exacerbations were defined as two or more
exacerbations in a year.
Results: Mean age of patients was 70.3  11.8 SD years. P wave dispersion was greater during
acute exacerbation than during stable phase (56.7  19.2 vs 47.7  15.9 ms, pZ 0.009). There
was a trend toward greater QTc dispersion (108.3  61.7 vs 90.3  47.0 ms, pZ 0.13) in acute
exacerbation compared to stable phase. Sixteen (53%) had frequent exacerbations. There was
a significant difference in PR interval during stable phase between those with frequent exac-
erbations and those without (163.9 þ 17.4 vs. 145.1 þ 22.8; pZ 0.02). The P wave dispersion
during stable phase was greater in those with frequent exacerbations, but did not reach statis-
tical significance (52.6 þ 18.8 vs. 42.2 þ 9.8 ms; p Z 0.06).
Conclusions: P wave dispersion is more in the acute phase than in stable phase, and is greater
in patients with more frequent exacerbations. This does not prove, but suggests an intriguing9 356 4419; fax: þ1 319 353 6406.
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Role of arrhythmias in acute exacerbations of COPD 1135possibility that P wave dispersion predates acute exacerbations. This might be a new target for
prediction, prevention and therapy of acute exacerbations of COPD.
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Acute exacerbations of chronic obstructive pulmonary
disease (COPD) are associated with considerable morbidity
and mortality.1 They are thought to be usually due to
infections, air pollution, change in humidity, and non-
compliance with medications.2 About a third, however
appear to occur without a precipitating cause.2 There is
increasing recognition that COPD is not a simple respiratory
disorder. The close inter-relation between the lungs and
the heart is affected in COPD, in the form of high rates of
diastolic dysfunction, recognition of arrhythmias like
multifocal atrial tachycardias and cor pulmonale.3,4
Heterogeneous ventricular repolarization and ventricular
arrhythmias have been shown to occur in COPD patients.5e8
QT dispersion is more in stable COPD patients compared to
age and sex matched normal controls.8 Moreover, arrhyth-
mias are commonly seen in patients with acute exacerba-
tions.9,10 These arrhythmias are commonly believed to be
due to disturbances in oxygen, carbon dioxide and pH.6,11
Autonomic dysfunction has also been observed.5,12 It is
not known if the arrhythmias are secondary to exacerba-
tions and the resulting acid base disturbances; or whether
arrhythmias lead to exacerbation. In the current study,
recognizing the close inter-relation between heart and
lung, and the relation between vascular congestion and
bronchial hyper-reactivity, we hypothesized that unrecog-
nized arrhythmias might be precipitants of acute exacer-
bations. We sought to test this hypothesis by comparing
surface electrocardiogram (ECG) indices of heterogeneity
in atrial depolarization and ventricular repolarization in
subjects with acute exacerbation of COPD with the same
indices when in stable phase, and also between subjects
with frequent and infrequent exacerbations. We further
attempted to determine if the repolarization abnormalities
primarily arose from the strained right side of the heart,
defining a right sided electropathy.Methods
Consecutive patients with principal discharge diagnosis of
acute exacerbation of COPD who had been hospitalized at
a tertiary care center were included. The study was
exempted from review by the Institutional Review Board
because all data was de-identified at the time of analysis.
The requirement for informed patient consent was waived
by the Institutional Review Board. Only those patients with
spirometry confirmed diagnosis of COPD were included.13
Those with secondary diagnoses of congestive heart
failure, coronary artery disease, chronic renal failure,
chronic respiratory conditions other than COPD, carcinoma
lung and those with evidence of pneumonia on chest
radiograph were excluded. Patients with chronic atrial
fibrillation; multifocal tachycardia; and conditions whichmade assessment of QT dispersion (QTd) imprecise, like
bundle branch block and hypokalemia, were excluded.
Those who required invasive mechanical ventilation were
excluded as this could cause right ventricular strain.
Patients using drugs that could prolong the QT interval,
such as antiarrhythmics (amiodarone, sotalol, procaina-
mide, disopyramide, quinidine), antibiotics (macrolides),
and psychiatric medications (tricyclic antidepressants,
phenothiazines, haloperidol), were also excluded.
Clinical and demographic data were recorded. This
included age; smoking status and number of pack-years;
presence of co-morbidities such as diabetes mellitus,
hypertension, depression, cerebrovascular disease; and
current pulmonary function test results (those within 2
years of admission). Active smokers were defined as those
who had smoked within the previous 6 months. Laboratory
data recorded included hematocrit, renal function tests,
and arterial blood gas analysis obtained within 6 h of
hospitalization. Electrolytes potentially affecting QT
interval such as potassium and magnesium were measured.
Serum calcium was adjusted for serum albumin levels.
Serum CPK and troponin were recorded at the time of
admission to rule out subtle ischemia.
Patients were followed for the next one year or till next
readmission for acute exacerbation of COPD, whichever
was longer. The number of readmissions for acute exacer-
bations in one year after index admission was recorded, and
the time to readmission calculated. Frequent exacerba-
tions were defined as two or more hospital visits for acute
exacerbations in a year.
Electrocardiogram analyses
The first 12-lead surface electrocardiogram obtained in the
emergency department at the time of admission for acute
exacerbation and the first electrocardiogram within 12
months on either side of admission when stable but not
within 1 month of index admission or exacerbation was used
for measurements by a single blinded observer. All ECGs
were enlarged to 200% of actual size using a photocopier.
All measurements were made manually using an ECG
caliper. The QT interval was measured to assess ventricular
repolarization. The QT interval was measured from the
onset of QRS complex to the end of Twave. In the presence
of inverted T waves, the point where the trace returned to
baseline (defined as the TeP segment) was taken as the end
of the QT interval. In the presence of U wave, the QT
interval was deemed to have ended at the lowest point
between the T wave and the U wave.6 In case of unclear T
wave termination, the ECG was discarded and the next
available ECG was used for measurements. Measurements
were made in all 12 leads. The QT dispersion (QTd) was
calculated by subtracting the minimum duration of the QT
interval from the maximum QT duration. ReR intervals
were measured for all leads. All QT intervals were
Table 2 Electrocardiographic measurements in stable and
acute phases.
Variable Stable Acute p value
Heart rate (per min) 83.2  17.7 88.5  16.7 0.21
PR (ms) 155.4  21.8 162.1  41.0 0.42
QRS (ms) 85.7  14.2 86.1  13.2 0.78
QT (ms) 361.4  36.5 355.2  36.4 0.48
QTc (ms) 418.4  18.1 425.2  20.2 0.13
P axis (deg) 63.2  20.0 63.3  17.7 0.94
R axis (deg) 39.3  72.8 20.0  43.8 0.18
T axis (deg) 61.7  32.6 62.5  27.1 0.87
Pheight (mm) 3.02  0.95 3.37  1.38 0.20
Pmax width (ms) 231.2  29.6 237.2  30 0.28
PWd (ms) 47.7  16 56.7  19 0.009*
QTd (ms) 157.2  78.4 170  112 0.58
QTcd (ms) 90.3  47.0 108.3  61.7 0.13
Right QTd (ms) 48  44 70  104 0.23
Left QTd (ms) 38  44 38  44 0.24
Right QTcd (ms) 30  21 42  55 0.24
Left QTcd (ms) 26  30 23  27 0.75
All values expressed as mean þ SD. Pmax width Z maximum
width of P wave in all 12 leads. PWd Z P wave dispersion.
QTd Z QT dispersion. QTcd Z QTc dispersion. *p < 0.05.
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OReR. QTc dispersion (QTcd) was similarly calculated.
Further, V1 and V2 were defined as right sided leads and V5
and V6 were defined as left sided leads. The difference in
QT duration in these leads were calculated to assess right
and left sided QT dispersions. This was to discern if there
was a difference in QT dispersion on the right side due to
right ventricular strain.
To assess heterogeneity of atrial depolarization, the
width of P wave was measured in all 12 leads of the surface
ECG. P wave duration was measured from the beginning of
the P wave deflection from baseline (TeP segment) to the
point where the P wave returned to baseline. P wave
dispersion (PWd) was calculated by subtracting the
minimum width of the P wave from the max P wave dura-
tion. The mean P, QRS and Twave axes were recorded from
the electronic data indicated on the ECG record.
Statistical analyses
Continuous variables were expressed as mean  SD, except
for time to readmission for which median was calculated.
Categorical variables were expressed as frequencies and
percentages. Paired t test was used to compare QT, QTc,
QTd, QTcd, Pmax and PWd in patients during acute exac-
erbation and when stable. Independent t test was used to
compare ECG indices and laboratory parameters between
patients with frequent and infrequent exacerbations.
Finally, Cox proportional hazards regression was used to
calculate the effect of PWd on time to readmission,
p < 0.05 was considered significant in all cases. All analyses
were done using SPSS version 11.5 (SPSS Inc., Chicago, IL).
Results
Thirty patients meeting all inclusion criteria were included
in the study. The demographic and clinical data for theTable 1 Baseline demographic and clinical data.
Variable n Z 30
Age (years) 70.3  11.8
Sex (%Male) 17 (57)
Smoker
Current (%) 9 (30)
Ex (%) 18 (60)
FEV1 (L) 1.3  0.5






Home oxygen (%) 11 (37)
Frequent exacerbations (%) 16 (53)
Time to readmission in days (Median; range) 117.5 (1e837)
All values expressed as mean þ SD unless otherwise mentioned.
FEV1 Z Forced expiratory volume in the first second.study population is shown in Table 1. Ninety percent were
active- or ex- smokers.
Twenty seven (90%) were readmitted for acute exacer-
bation within a year of index hospitalization, and 7 (23%) of
them were readmitted within a month of initial hospitali-
zation. Table 2 describes the electrocardiographic
measurements during acute exacerbations and stable pha-
ses. The P wave dispersion was significantly greater in acute
phase compared to stable phase (56.7  19 vs.
47.7 þ 16 ms; p Z 0.009. See Fig. 1). There was a similar
trend in QTc dispersion but this did not reach statistical
significance. There was no difference between right and
left sided QT and QTc dispersions.
Sixteen (53%) had frequent exacerbations. There was
a significant difference in PR interval during stable phase
between those with frequent exacerbations and thoseFigure 1 Comparison of P wave dispersion between stable
and acute phases. All values are expressed as Mean  SD in ms.
p Z 0.009.
Figure 3 Cox proportional hazards analysis of relationship
between P wave dispersion in stable phase and time to read-
mission. Hazards ratio Z 1.5 (95%CI 0.9e2.6); p Z 0.11.
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wave dispersion during stable phase was greater in those
with frequent exacerbations, but did not reach statistical
significance (52.6  18.8 vs. 42.2  9.8 ms; p Z 0.06. See
Fig. 2). There was no difference in other measures of
dispersion. There was no difference in FEV1% predicted
between the two groups (55.9  16.3 vs. 46.5  23.4;
p Z 0.24). There was also no difference in age, baseline
electrolytes and PaO2 between the two groups. There was
also no correlation between these variables and P wave
dispersion in the stable phase. Results of Cox proportional
regression analysis showed that the higher the P wave
dispersion, the shorter the time to readmission was
(hazards ratio 1.5, 95%CI 0.9 to 2.6; p Z 0.11. See Fig. 3).
Discussion
Our study has two important findings. First, there was
a significant difference in P wave dispersion in the same
subjects in stable and acute phases. Second, the stable
phase P wave dispersion was higher in patients with
frequent exacerbations than in those without, though this
did not reach statistical significance. This latter occurrence
was likely due to small numbers of subjects studied. A
greater P wave dispersion also shortened the time to
readmission by a factor of 1.5. P wave represents atrial
depolarization. Increased dispersion represents inhomoge-
neous conduction and electrical remodeling. This does not
prove but is supportive of our hypothesis that unrecognized
electrical remodeling and arrhythmias lead to, or cause
a predisposition to, acute exacerbations of COPD.
This occurrence is biologically plausible. There is a very
high incidence of diastolic dysfunction in patients with
COPD, though we did not specifically look for this in our
study.3 Any supraventricular arrhythmia, paroxysmal or
sustained, can cause impairment of diastolic function.
There is a close relationship between vascular congestion in
pulmonary vessels and bronchial reactivity.14 This could
lead to decompensation of stable phase in these patients.
This has implications in that it leads to new targets for both
therapy and prevention. In fact, a large proportion of COPD
mortality is not of pulmonary origin.15 Currently, there areFigure 2 Comparison of P wave dispersion in the stable
phase between subjects with frequent and non frequent
exacerbations. p Z 0.06.two major hypotheses to explain arrhythmias in COPD. One
states that arrhythmias are secondary to hypoxemia,
hypercapnia and acid base disturbances.6 A second
hypothesis is that of increased autonomic activity, with
both increased sympathetic and lowered parasympathetic
activity being proposed.12 While some studies have specu-
lated that hypoxemia predisposes to autonomic neurop-
athy,16,17 others have failed to find this association.18,19 We
did not find any correlation between measures of dispersion
and acid base disturbances.
Multiple experimental studies have established repolar-
ization dispersion as an arrhythmogenic substrate.20,21 Zulli
et al found that QT dispersion was an independent
predictor of mortality in patients with COPD.7 Interestingly,
they found that QT dispersion greater than 48 ms and QTc
dispersion greater than 55 ms were independent predictors
of mortality from respiratory causes. Increased P wave
dispersion reflects inhomogeneous atrial impulse conduc-
tion, and has been shown to predict development of
paroxysmal atrial fibrillation in different patient pop-
ulations22e24 Prolonged, inhomogeneous and anisotropic
conduction of electrical impulses between atrial fibers
predisposes to supraventricular arrhythmias. These are
reflected in the surface ECG by prolonged P wave duration
and a wide range between the maximum and minimum P
wave widths on a 12-lead ECG.25 Tutek et al showed that
the maximum duration of P wave and the P wave dispersion
were higher in COPD patients compared to age and sex
matched controls.26 They also found that P wave dispersion
was significantly higher in COPD patients with paroxysmal
atrial fibrillation when compared to those without parox-
ysmal atrial fibrillation. P wave dispersion did not correlate
with oxygen, carbon dioxide or acid base abnormalities.
They concluded that the presence of COPD predicted
increased P wave dispersion. Our study is the first to show
that P wave dispersion is more in the acute phase than in
stable phase, and that P wave dispersion is greater in
patients with more frequent exacerbations. This suggests
electrical remodeling and strain is more in the acute phase
of patients with frequent COPD exacerbations.
1138 S.P. Bhatt et al.Our study has many limitations. The sample size was
small, and was not based on power calculations. The ECG
data was collected retrospectively and the follow up was
done prospectively. The ECG measurements were done
manually by a single observer. However, this observer was
blinded, well qualified to measure ECG intervals, and
omitted ECGs not amenable to adequate measurements.
Most previous studies have used the same techniques. Also,
automatic measurement of QT dispersion has not been
shown to be superior to manual measurements.27 Echo-
cardiogram was not performed in many of these patients,
nor invasive tests to assess coronary artery disease. This,
however, was not the aim of this study, and we relied on
medical records to exclude these variables. While we used
easily available surrogate markers of arrhythmias, stronger
evidence would come from using event loop recorders in
a similar cohort of subjects.
In conclusion, our study showed that P wave dispersion is
more in the acute phase than in stable phase, and that P
wave dispersion is greater in patients with more frequent
exacerbations. This does not prove, but suggests an
intriguing possibility that P wave dispersion predates acute
exacerbations. This might be a new target for prediction,
prevention and therapy of acute exacerbations of COPD.
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